Timbangan, Kaisha M.

HRN: 23-30-83  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2023
CEFUROXIME 750MG (VIAL)
07/14/2023
07/20/2023
IVT
630
Q8
UTI
Checking Final Appropriateness 
07/18/2023
CEFTRIAXONE 1G (VIAL)
07/18/2023
07/24/2023
IVT
2grams
Q24h
UTI
Checking Final Appropriateness 
07/18/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/18/2023
07/24/2023
IVTT
400mg
Q8h
UTI, R/O ASA

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: